Post

cool study of my health code, a (non commercial) tablet-based #EndOfLife intervention for patients in the ER to get #GoalsOfCare conversations started & advanced #ACEP26

1 in 4 ED-initiate hospice & palliative care consults don’t end up being completed of those completed, <12h average time, much faster for hospice than palliative #acep26

small study of EM residents: report low amounts of palliative education, low confidence in skills, they WANT more palliative care education, and maybe a link with improved burnout #ACEP26

LLMs can be useful for chart review for ED resus/#EndOfLife conversations research #ACEP26

as states banned non medical vaccine exemptions, medical exemptions went up except in Mississippi where exemptions are (were) limited (previously to own the crunchy libs) @jeremyfaust.bsky.social at #ACEP26

tamiflu probably does work, might hurt in flu @jeremyfaust.bsky.social at #ACEP26

mRNA flu vaccine a bit more effective, a bit more side effects (myalgias, HA and such) @jeremyfaust.bsky.social at #ACEP26

Paxlovid probably doesn’t decrease hospitalizations (including immunocompromised), probably at least partially because COVID hospitalizations are low now @jeremyfaust.bsky.social at #ACEP26

ensiltrivir (antiviral) PEP for COVID decreased household contact infections @jeremyfaust.bsky.social at #ACEP26

Vanishingly low clinical utility in modern times, not to mention economically unfavorable.

I guess good to know if prevalence jumps up again?

And/or illness severity – but that would likewise assume the new mutations wouldn't change its susceptibility to the antiviral (though I suspect protease inhibition is fairly robust to spike protein changes). The U.S. is a funny case of dramatically higher antiviral use than much of the world.